Raymond James Financial Services Advisors, Inc. - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 109 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2023$7,431
-19.0%
14,5700.0%0.00%
Q1 2023$9,179
-3.1%
14,570
-0.1%
0.00%
Q4 2022$9,468
-72.9%
14,586
-28.2%
0.00%
Q3 2022$35,000
+40.0%
20,309
-0.1%
0.00%
Q2 2022$25,000
+177.8%
20,335
+47.0%
0.00%
Q1 2022$9,000
-60.9%
13,835
-33.6%
0.00%
Q4 2021$23,000
-47.7%
20,835
-14.6%
0.00%
Q3 2021$44,000
-15.4%
24,406
+23.3%
0.00%
Q2 2021$52,000
-40.2%
19,796
-18.4%
0.00%
Q1 2021$87,000
+89.1%
24,270
+34.0%
0.00%
Q4 2020$46,0000.0%18,106
-1.7%
0.00%
Q3 2020$46,000
-29.2%
18,416
-7.1%
0.00%
Q2 2020$65,000
+32.7%
19,8160.0%0.00%
Q1 2020$49,000
-57.4%
19,816
-18.5%
0.00%
Q4 2019$115,000
-63.3%
24,302
-54.7%
0.00%
-100.0%
Q2 2019$313,000
+84.1%
53,628
+21.8%
0.00%0.0%
Q1 2019$170,000
+93.2%
44,038
-6.2%
0.00%
Q4 2018$88,000
-79.6%
46,925
-70.3%
0.00%
-100.0%
Q2 2018$432,000
-28.4%
158,094
-4.1%
0.00%
-33.3%
Q1 2018$603,000
-2.4%
164,883
+10.4%
0.00%
-25.0%
Q4 2017$618,000
-27.0%
149,390
+8.3%
0.00%
-20.0%
Q3 2017$847,000
+3.4%
137,998
+4.8%
0.01%
-16.7%
Q2 2017$819,000
-3.9%
131,722
-2.0%
0.01%0.0%
Q1 2017$852,000
+16.6%
134,417
-31.4%
0.01%0.0%
Q4 2016$731,000
-22.6%
196,047
-18.0%
0.01%
-25.0%
Q3 2016$944,000
-13.1%
239,116
-14.4%
0.01%
-20.0%
Q2 2016$1,086,000
-24.5%
279,354
+37.1%
0.01%
-37.5%
Q1 2016$1,438,000
-6.7%
203,744
+9.9%
0.02%
-11.1%
Q4 2015$1,541,000
+49.0%
185,444
+61.6%
0.02%
+5.9%
Q3 2015$1,034,000114,7630.02%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders